Melanocyte-stimulating-hormone levels in doxorubicin-induced hyperpigmentation.
D004317:Doxorubicin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006225:Hand; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy; D009074:Melanocyte-Stimulating Hormones / Q000097:blood*; D010859:Pigmentation Disorders / Q000097:blood / Q000139:chemically induced*
D004317:Doxorubicin; D009074:Melanocyte-Stimulating Hormones